Digoxin Oral Solution

— THERAPEUTIC CATEGORIES —
  • CHF and arrhythmias

Digoxin Oral Solution Generic Name & Formulations

General Description

Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%.

Pharmacological Class

Cardiac glycoside.

How Supplied

Soln—60mL

Digoxin Oral Solution Indications

Indications

Mild-to-moderate heart failure (with a diuretic and an ACE inhibitor when possible). Increase myocardial contractility in pediatrics with heart failure. Control of ventricular response rate in chronic atrial fibrillation.

Digoxin Oral Solution Dosage and Administration

Adult

Individualize: see full labeling. Initially 0.003mg/kg per day. Monitor digoxin levels.

Children

Individualize: see full labeling. >2yrs: initially 0.01mg/kg per day. Monitor digoxin levels.

Digoxin Oral Solution Contraindications

Contraindications

Ventricular fibrillation.

Digoxin Oral Solution Boxed Warnings

Not Applicable

Digoxin Oral Solution Warnings/Precautions

Warnings/Precautions

Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome). Heart failure with preserved LV ejection fraction (eg, restrictive cardiomyopathy, constrictive pericarditis, amyloid heart disease, acute cor pulmonale, hypertrophic cardiomyopathy). Electrical cardioversion. Acute MI. Avoid in myocarditis. Toxicity risk increased by hypokalemia, hypomagnesemia, hypercalcemia, diabetes. Hypocalcemia may nullify effects. Thyroid disease. Hypermetabolic states. Monitor digoxin levels, electrolytes, renal function. Elderly. Children. Infants. Pregnancy (Cat.C). Nursing mothers.

Digoxin Oral Solution Pharmacokinetics

See Literature

Digoxin Oral Solution Interactions

Interactions

Toxicity risk increased by potassium-depleting drugs (eg, diuretics, amphotericin B, corticosteroids). Digoxin levels increased by antibiotics (eg, macrolides, tetracyclines), amiodarone, dronedarone, propafenone, quinidine, quinine, ritonavir, verapamil, indomethacin, itraconazole, lapatinib, mirabegron, spironolactone, telaprevir, drugs that reduce GI motility (eg, propantheline, diphenoxylate), thyroid antagonists, drugs that reduce renal function, others. Digoxin levels decreased by thyroid hormones, antacids, kaolin-pectin, cholestyramine, neomycin, penicillamine, rifampin, sulfasalazine, drugs that increase GI motility (eg, metoclopramide), certain antineoplastics, others. Digoxin levels possibly affected by alprazolam, cyclosporine, diclofenac, others. Arrhythmias with sympathomimetics, succinylcholine, or rapid calcium infusion. Heart block with drugs that affect cardiac conduction (eg, calcium channel blockers, β-blockers). Increased risk of bradycardia with ivabradine.

Digoxin Oral Solution Adverse Reactions

Adverse Reactions

GI upset, anorexia, CNS effects (eg, blurred or yellow vision, or mental disturbances, confusion, headache, weakness, dizziness, apathy), gynecomastia, rash, heart block, arrhythmias (esp. children).

Digoxin Oral Solution Clinical Trials

See Literature

Digoxin Oral Solution Note

Not Applicable

Digoxin Oral Solution Patient Counseling

See Literature